1. Home
  2. PRTA vs MTW Comparison

PRTA vs MTW Comparison

Compare PRTA & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • MTW
  • Stock Information
  • Founded
  • PRTA 2012
  • MTW 1902
  • Country
  • PRTA Ireland
  • MTW United States
  • Employees
  • PRTA N/A
  • MTW N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • PRTA Health Care
  • MTW Industrials
  • Exchange
  • PRTA Nasdaq
  • MTW Nasdaq
  • Market Cap
  • PRTA 472.1M
  • MTW 358.5M
  • IPO Year
  • PRTA N/A
  • MTW N/A
  • Fundamental
  • Price
  • PRTA $8.20
  • MTW $9.89
  • Analyst Decision
  • PRTA Buy
  • MTW Hold
  • Analyst Count
  • PRTA 10
  • MTW 4
  • Target Price
  • PRTA $14.86
  • MTW $11.00
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • MTW 381.2K
  • Earning Date
  • PRTA 08-04-2025
  • MTW 08-07-2025
  • Dividend Yield
  • PRTA N/A
  • MTW N/A
  • EPS Growth
  • PRTA N/A
  • MTW 436.41
  • EPS
  • PRTA N/A
  • MTW 1.26
  • Revenue
  • PRTA $10,341,000.00
  • MTW $2,131,200,000.00
  • Revenue This Year
  • PRTA N/A
  • MTW N/A
  • Revenue Next Year
  • PRTA $389.77
  • MTW $4.66
  • P/E Ratio
  • PRTA N/A
  • MTW $7.86
  • Revenue Growth
  • PRTA N/A
  • MTW N/A
  • 52 Week Low
  • PRTA $4.32
  • MTW $7.06
  • 52 Week High
  • PRTA $22.83
  • MTW $13.62
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • MTW 38.48
  • Support Level
  • PRTA $8.05
  • MTW $9.91
  • Resistance Level
  • PRTA $8.73
  • MTW $10.19
  • Average True Range (ATR)
  • PRTA 0.38
  • MTW 0.35
  • MACD
  • PRTA -0.05
  • MTW 0.08
  • Stochastic Oscillator
  • PRTA 47.62
  • MTW 61.07

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks: